Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic non-dystrophic myopathy characterized by the triad of congenital myopathy, dysmorphic features and susceptibility to malignant hyperthermia. Patients present with a wide phenotypic range, including delayed motor development, muscle weakness and fatigability, ptosis and facies myopathica (with or without creatine kinase elevations), skeletal abnormalities (e.g. short stature, scoliosis, kyphosis, lumbar lordosis and pectus carinatum/excavatum), mild dysmorphic facial features (e.g. hypertelorism, down-slanting palpebral fissures, epicanthic folds, low set ears, micrognathia), webbing of the neck, cryptorchidism, and a susceptibility to malignant hyperthermia and/or rhabdomyolysis due to intensive physical strain, viral infection or statin use.
Features include always present findings: Scaphocephaly, Deep philtrum, Muscle fiber atrophy, and Weakness of facial musculature and others; and very common findings: Low muscle tone (hypotonia), Excessive inward curve of the lower back (lumbar hyperlordosis), and Ptosis. 38 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 9 | Low muscle tone (hypotonia), Muscle fiber atrophy, Weakness of facial musculature |
RYR1 function has not been fully characterized.
King-Denborough syndrome is associated with mutations in the RYR1 gene on chromosome 19.
Genetic testing for RYR1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 20 always present features, 3 very common features, 14 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for King-Denborough syndrome.
3 publications have been identified in PubMed for King-Denborough syndrome. Research spans Epidemiology / Natural History (67%) and Case Report / Case Series (33%).
Ginsberg M (2026). [PMID: 41753076](https://pubmed.ncbi.nlm.nih.gov/41753076/). *J Clin Med*. [Epidemiology / Natural History]
Schoonen M (2025). [PMID: 39966651](https://pubmed.ncbi.nlm.nih.gov/39966651/). *Eur J Hum Genet*. [Epidemiology / Natural History]
Geng Z (2025). [PMID: 40410924](https://pubmed.ncbi.nlm.nih.gov/40410924/). *J Med Case Rep*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Oct 3, 2026, 8:12 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about King-Denborough syndrome
Bones and joints | 6 | Excessive inward curve of the lower back (lumbar hyperlordosis), Kyphoscoliosis, Centrally nucleated skeletal muscle fibers |
Growth and development | 2 | Short stature, Failure to thrive |
Head and neck | 2 | Weakness of facial musculature, High palate |
Eyes | 2 | Bilateral ptosis, Ptosis |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Heart and blood vessels | 1 | Ventricular septal defect |
Pregnancy and birth | 1 | Decreased fetal movement |